---

$10.60

-0.5800 ( -5.19% ) 111.2K

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-04-24	Buy	17857.00	BASKETT FOREST
2024-04-24	Buy	17857.00	New Enterprise Associates 17, L.P.
2024-04-24	Buy	17857.00	Mathers Edward T
2024-04-24	Buy	17857.00	Yang Rick
2024-04-24	Buy	17857.00	Makhzoumi Mohamad
2024-04-24	Buy	17857.00	SANDELL SCOTT D
2024-04-24	Buy	17857.00	Chang Carmen
2024-04-23	Sale	-17857.00	FORMELA JEAN FRANCOIS
2024-04-23	Buy	17857.00	Atlas Venture Opportunity Fund II, L.P.
2023-11-29	Sale	-12551.00	Meyers Rachel